Interpretation of 2019 International Working Group on Diabetic Foot guidelines on the prevention and management of diabetic foot disease_Chinese Journal of Reparative and Reconstructive Surgery

Authors：

GAO Lei ,  WANG Jiangning , YIN Yefeng

Department of Orthopaedic Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, P.R.China;

Corresponding?author：

WANG Jiangning, Email: dlwangjn@vip.sina.com

Keywords：

International Working Group on Diabetic Foot; diabetic foot; prevention; treatment; guideline

DOI：

10.7507/1002-1892.201906014

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

The 8th World International Symposium on the Diabetic Foot (ISDF) Conference which was sponsored by the International Working Group on Diabetic Foot (IWGDF) was held in the Hague between May 22nd and May 25th, 2019. The conference issued the 2019 IWGDF guidelines on the prevention and management of diabetic foot disease. The update to the 2015 edition of the guidelines involves the following 6 chapters: prevention of foot ulcers in patients with diabetes; offloading foot ulcers in patients with diabetes; diagnosis, prognosis, and management of peripheral arterial disease in patients with a foot ulcer and diabetes; diagnosis and treatment of foot infection in patients with diabetes; interventions to enhance healing of foot ulcers in patients with diabetes; classification of diabetic foot ulcers. This guideline has been changed more than the previous edition. In this paper, the guidelines will be interpreted to provide cutting-edge information for domestic diabetic foot researchers.

Citation： GAO Lei, WANG Jiangning, YIN Yefeng. Interpretation of 2019 International Working Group on Diabetic Foot guidelines on the prevention and management of diabetic foot disease. Chinese Journal of Reparative and Reconstructive Surgery, 2020, 34(1): 16-20. doi: 10.7507/1002-1892.201906014 Copy

1.	Bus SA, van Netten JJ, Lavery LA, et al. IWGDF guidance on the prevention of foot ulcers in at-risk patients with diabetes. Diabetes Metab Res Rev, 2016, 32(Suppl 1): 16-24.
2.	Coffey L, Mahon C, Gallagher P. Perceptions and experiences of diabetic foot ulceration and foot care in people with diabetes: A qualitative meta-synthesis. Int Wound J, 2019, 16(1): 183-210.
3.	Keukenkamp R, Merkx MJ, Busch-Westbroek TE, et al. An explorative study on the efficacy and feasibility of the use of motivational interviewing to improve footwear adherence in persons with diabetes at high risk for foot ulceration. J Am Podiatr Med Assoc, 2018, 108(2): 90-99.
4.	Jeffcoate WJ, Vileikyte L, Boyko EJ, et al. Current challenges and opportunities in the prevention and management of diabetic foot ulcers. Diabetes Care, 2018, 41(4): 645-652.
5.	Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med, 2017, 376(24): 2367-2375.
6.	Bus SA. The role of pressure offloading on diabetic foot ulcer healing and prevention of recurrence. Plast Reconstr Surg, 2016, 138(3 Suppl): 179S-187S.
7.	王江寧, 高磊. 糖尿病足慢性創面治療的新進展. 中國修復重建外科雜志, 2018, 32(7): 832-837.
8.	Randhawa MS, Reed GW, Grafmiller K, et al. Prevalence of tibial artery and pedal arch patency by angiography in patients with critical limb ischemia and noncompressible ankle brachial index. Circ Cardiovasc Interv, 2017, 10(5): pii: e004605.
9.	Rigato M, Pizzol D, Tiago A, et al. Characteristics, prevalence, and outcomes of diabetic foot ulcers in Africa. A systemic review and meta-analysis. Diabetes Res Clin Pract, 2018, 142: 63-73.
10.	Mills JL Sr, Conte MS, Armstrong DG, et al. The society for vascular surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg, 2014, 59(1): 220-234.
11.	Weaver ML, Hicks CW, Canner JK, et al. The society for vascular surgery wound, ischemia, and foot infection (WIfI) classification system predicts wound healing better than direct angiosome perfusion in diabetic foot wounds. J Vasc Surg, 2018, 68(5): 1473-1481.
12.	Ali SR, Ozdemir BA, Hinchliffe RJ. Critical appraisal of the quality of evidence addressing the diagnosis, prognosis, and management of peripheral artery disease in patients with diabetic foot ulceration. Eur J Vasc Endovasc Surg, 2018, 56(3): 401-408.
13.	Lipsky BA, Aragón-Sánchez J, Diggle M, et al. IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes. Diabetes Metab Res Rev, 2016, 32(Suppl 1): 45-74.
14.	Peters EJ, Lipsky BA, Aragón-Sánchez J, et al. Interventions in the management of infection in the foot in diabetes: a systematic review. Diabetes Metab Res Rev, 2016, 32(Suppl 1): 145-153.
15.	Uckay I, Jornayvaz FR, Lebowitz D, et al. An overview on diabetic foot infections, including issues related to associated pain, hyperglycemia and limb ischemia. Curr Pharm Des, 2018, 24(12): 1243-1254.
16.	Morozova VV, Kozlova YN, Ganichev DA, et al. Bacteriophage treatment of infected diabetic foot ulcers. Methods Mol Biol, 2018, 1693: 151-158.
17.	Fish R, Kutter E, Wheat G, et al. Compassionate use of bacteriophage therapy for foot ulcer treatment as an effective step for moving toward clinical trials. Methods Mol Biol, 2018, 1693: 159-170.
18.	Ndosi M, Wright-Hughes A, Brown S, et al. Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study. Diabet Med, 2018, 35(1): 78-88.
19.	Zha ML, Cai JY, Chen HL. A bibliometric analysis of global research production pertaining to diabetic foot ulcers in the past ten years. J Foot Ankle Surg, 2019, 58(2): 253-259.
20.	李雪梅, 張雨詩, 鐘科, 等. 改良型富血小板纖維蛋白與 β-磷酸三鈣復合物誘導骨再生的研究. 中國修復重建外科雜志, 2019, 33(2): 177-184.
21.	呂洋, 王江寧. 富血小板血液制品在組織創傷愈合中的應用進展. 中華醫學美學美容雜志, 2018, 24(3): 159-161.
22.	Miron RJ, Fujioka-Kobayashi M, Hernandez M, et al. Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry? Clin Oral Investig, 2017, 21(8): 2619-2627.
23.	Balse N, Baliga S. " Evaluation of wound healing and bone regeneration using autologous platelet-rich plasma and platelet-rich fibrin postextractions”: A comparative study. Indian Journal of Health Sciences and Biomedical Research (KLEU), 2017, 10(2): 167-172.
24.	Battiston B, Ciclamini D, Tang JB. Compound or specially designed flaps in the lower extremities. Clin Plast Surg, 2017, 44(2): 287-297.
25.	王壽宇, 呂德成, 王媛媛, 等. 蛆蟲分泌物對糖尿病大鼠潰瘍組織 bFGF 和結締組織生長因子表達的影響及抗菌作用研究. 中國修復重建外科雜志, 2008, 22(4): 472-475.
26.	高磊, 李天博, 劉燕玲, 等. 皮膚牽張閉合器在難愈性褥瘡創面修復中的應用. 中華顯微外科雜志, 2018, 41(1): 80-83.
27.	高磊, 王碩, 王雷, 等. 皮膚牽張閉合器在糖尿病足創面修復中的應用. 中國修復重建外科雜志, 2018, 32(5): 591-595.
28.	Game F. Classification of diabetic foot ulcers. Diabetes Metab Res Rev, 2016, 32(Suppl 1): 186-194.
29.	Jeon BJ, Choi HJ, Kang JS, et al. Comparison of five systems of classification of diabetic foot ulcers and predictive factors for amputation. Int Wound J, 2017, 14(3): 537-545.

1. Bus SA, van Netten JJ, Lavery LA, et al. IWGDF guidance on the prevention of foot ulcers in at-risk patients with diabetes. Diabetes Metab Res Rev, 2016, 32(Suppl 1): 16-24.
2. Coffey L, Mahon C, Gallagher P. Perceptions and experiences of diabetic foot ulceration and foot care in people with diabetes: A qualitative meta-synthesis. Int Wound J, 2019, 16(1): 183-210.
3. Keukenkamp R, Merkx MJ, Busch-Westbroek TE, et al. An explorative study on the efficacy and feasibility of the use of motivational interviewing to improve footwear adherence in persons with diabetes at high risk for foot ulceration. J Am Podiatr Med Assoc, 2018, 108(2): 90-99.
4. Jeffcoate WJ, Vileikyte L, Boyko EJ, et al. Current challenges and opportunities in the prevention and management of diabetic foot ulcers. Diabetes Care, 2018, 41(4): 645-652.
5. Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med, 2017, 376(24): 2367-2375.
6. Bus SA. The role of pressure offloading on diabetic foot ulcer healing and prevention of recurrence. Plast Reconstr Surg, 2016, 138(3 Suppl): 179S-187S.
7. 王江寧, 高磊. 糖尿病足慢性創面治療的新進展. 中國修復重建外科雜志, 2018, 32(7): 832-837.
8. Randhawa MS, Reed GW, Grafmiller K, et al. Prevalence of tibial artery and pedal arch patency by angiography in patients with critical limb ischemia and noncompressible ankle brachial index. Circ Cardiovasc Interv, 2017, 10(5): pii: e004605.
9. Rigato M, Pizzol D, Tiago A, et al. Characteristics, prevalence, and outcomes of diabetic foot ulcers in Africa. A systemic review and meta-analysis. Diabetes Res Clin Pract, 2018, 142: 63-73.
10. Mills JL Sr, Conte MS, Armstrong DG, et al. The society for vascular surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg, 2014, 59(1): 220-234.
11. Weaver ML, Hicks CW, Canner JK, et al. The society for vascular surgery wound, ischemia, and foot infection (WIfI) classification system predicts wound healing better than direct angiosome perfusion in diabetic foot wounds. J Vasc Surg, 2018, 68(5): 1473-1481.
12. Ali SR, Ozdemir BA, Hinchliffe RJ. Critical appraisal of the quality of evidence addressing the diagnosis, prognosis, and management of peripheral artery disease in patients with diabetic foot ulceration. Eur J Vasc Endovasc Surg, 2018, 56(3): 401-408.
13. Lipsky BA, Aragón-Sánchez J, Diggle M, et al. IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes. Diabetes Metab Res Rev, 2016, 32(Suppl 1): 45-74.
14. Peters EJ, Lipsky BA, Aragón-Sánchez J, et al. Interventions in the management of infection in the foot in diabetes: a systematic review. Diabetes Metab Res Rev, 2016, 32(Suppl 1): 145-153.
15. Uckay I, Jornayvaz FR, Lebowitz D, et al. An overview on diabetic foot infections, including issues related to associated pain, hyperglycemia and limb ischemia. Curr Pharm Des, 2018, 24(12): 1243-1254.
16. Morozova VV, Kozlova YN, Ganichev DA, et al. Bacteriophage treatment of infected diabetic foot ulcers. Methods Mol Biol, 2018, 1693: 151-158.
17. Fish R, Kutter E, Wheat G, et al. Compassionate use of bacteriophage therapy for foot ulcer treatment as an effective step for moving toward clinical trials. Methods Mol Biol, 2018, 1693: 159-170.
18. Ndosi M, Wright-Hughes A, Brown S, et al. Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study. Diabet Med, 2018, 35(1): 78-88.
19. Zha ML, Cai JY, Chen HL. A bibliometric analysis of global research production pertaining to diabetic foot ulcers in the past ten years. J Foot Ankle Surg, 2019, 58(2): 253-259.
20. 李雪梅, 張雨詩, 鐘科, 等. 改良型富血小板纖維蛋白與 β-磷酸三鈣復合物誘導骨再生的研究. 中國修復重建外科雜志, 2019, 33(2): 177-184.
21. 呂洋, 王江寧. 富血小板血液制品在組織創傷愈合中的應用進展. 中華醫學美學美容雜志, 2018, 24(3): 159-161.
22. Miron RJ, Fujioka-Kobayashi M, Hernandez M, et al. Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry? Clin Oral Investig, 2017, 21(8): 2619-2627.
23. Balse N, Baliga S. " Evaluation of wound healing and bone regeneration using autologous platelet-rich plasma and platelet-rich fibrin postextractions”: A comparative study. Indian Journal of Health Sciences and Biomedical Research (KLEU), 2017, 10(2): 167-172.
24. Battiston B, Ciclamini D, Tang JB. Compound or specially designed flaps in the lower extremities. Clin Plast Surg, 2017, 44(2): 287-297.
25. 王壽宇, 呂德成, 王媛媛, 等. 蛆蟲分泌物對糖尿病大鼠潰瘍組織 bFGF 和結締組織生長因子表達的影響及抗菌作用研究. 中國修復重建外科雜志, 2008, 22(4): 472-475.
26. 高磊, 李天博, 劉燕玲, 等. 皮膚牽張閉合器在難愈性褥瘡創面修復中的應用. 中華顯微外科雜志, 2018, 41(1): 80-83.
27. 高磊, 王碩, 王雷, 等. 皮膚牽張閉合器在糖尿病足創面修復中的應用. 中國修復重建外科雜志, 2018, 32(5): 591-595.
28. Game F. Classification of diabetic foot ulcers. Diabetes Metab Res Rev, 2016, 32(Suppl 1): 186-194.
29. Jeon BJ, Choi HJ, Kang JS, et al. Comparison of five systems of classification of diabetic foot ulcers and predictive factors for amputation. Int Wound J, 2017, 14(3): 537-545.

Chinese Journal of Reparative and Reconstructive Surgery

Interpretation of 2019 International Working Group on Diabetic Foot guidelines on the prevention and management of diabetic foot disease

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content